Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCrimson Tide Regulatory News (TIDE)

Share Price Information for Crimson Tide (TIDE)

Share Price is delayed by 15 minutes
Get Live Data
92.50    5.00 (5.71%)
Bid:
90.00
Ask:
95.00
Spread: 5.00 (5.556%)
Market Cap: £6.08m
TIDE Live PriceLast checked at - London Stock Exchange

Intraday Crimson Tide Share Chart

Technology provider for study on ageing

7 Apr 2010 07:00

RNS Number : 7582J
Crimson Tide PLC
07 April 2010
 



Crimson Tide Plc

("Crimson Tide" or the "Company")

CRIMSON TIDE TECHNOLOGY KEEPS IRISH GOVERNMENT PROJECT SECURE

Crimson Tide, the mobile software technologies company, is pleased to announce that a ten year study initiated by the Irish Government to ensure that the needs of its older people are met, is utilising an advanced mobile system developed by the Company to guarantee security and confidentiality.

 TILDA (The Irish LongituDinal Study on Ageing) was launched by Minister for Health Mary Harney in November 2006, to study a representative sample of at least 8,000 people, aged 50 years and over and resident in Ireland. It charts their health, social and economic circumstances over a 10-year period.

The study is being carried out across the whole of Ireland by Trinity College Dublin in collaboration with a panel of scientific researchers and international scientists with expertise in various fields of ageing. Crimson Tide's system ensures this operation is carried out in a secure and confidential manner using mobile portable technology. 

The application is centred around the Motorola MC55 hand held device and requires the user to identify and capture each respondent's details. It enables the user to move through a series of screens, adding additional data relevant to the project, as they proceed. 

 The system uses real time GPRS data transfer to ensure that records are updated immediately after each visit, and the hand held device interacts with a number of application-based tests carried out on a laptop computer. All information gathered is kept strictly confidential and used only for research purposes.

Says Dr Hilary Cronin, Medical Director for TILDA: "Crimson Tide is an exceptional company to work with and I cannot recommend them highly enough. Their people are incredibly efficient and so pleasant to deal with. They spent time ensuring that our technology interfaces were user friendly and intuitive. Our initially 'techno-phobic' research nurses now love their PDA's and can't imagine collecting data without them! It has significantly improved the way we conduct our clinical research. Their technologies are now an integral part of our study and I look forward to working with them again in the future."

Crimson Tide Director Laurence Darcy says: "It has been a privilege to work on this study with Trinity College Dublin to develop a state-of-the art mobile data solution. We are working on a range of solutions in the healthcare sector and expect to have more innovative solutions coming to the market this year."

- ends -

For further information, contact:

Crimson Tide plc

Barrie Whipp, Executive Chairman

 

01892 542 444

Threadneedle Communications

Graham Herring/Josh Royston

 

020 7653 9850

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRAXQLFBBZFXBBD
Date   Source Headline
7th Mar 202510:20 amRNSForm 8.5 (EPT/RI)
6th Mar 20259:22 amRNSForm 8.5 (EPT/NON-RI)
5th Mar 202511:07 amRNSForm 8.5 (EPT/RI)
4th Mar 20254:48 pmRNSForm 8.3 - Crimson Tide PLC
4th Mar 202510:00 amRNSForm 8.5 (EPT/RI)
3rd Mar 202512:13 pmRNSForm 8.5 (EPT/RI)
27th Feb 202511:07 amRNSForm 8.5 (EPT/RI)
26th Feb 20254:42 pmRNSForm 8.3 - Crimson Tide plc
26th Feb 20254:11 pmRNSForm 8.5 (EPT/NON-RI) - Amendment
26th Feb 20252:09 pmRNSForm 8.3 - Crimson Tide PLC
26th Feb 20258:34 amRNSForm 8.5 (EPT/NON-RI)
25th Feb 20253:00 pmRNSForm 8.3 - Crimson Tide PLC
25th Feb 202511:51 amRNSForm 8.5 (EPT/NON-RI) - Amendment
25th Feb 202511:33 amRNSForm 8.5 (EPT/RI)
24th Feb 202511:52 amRNSForm 8.5 (EPT/RI)
24th Feb 202510:42 amRNSForm 8.3 - Crimson Tide plc
21st Feb 202510:30 amRNSForm 8.3 - Crimson Tide plc - Replacement
20th Feb 20252:08 pmGNWForm 8.3 - Crimson Tide Plc
20th Feb 20252:00 pmRNSForm 8.3 - Crimson Tide plc
20th Feb 202511:33 amRNSForm 8.3 - CRIMSON TIDE PLC
20th Feb 202510:39 amRNSForm 8.5 (EPT/RI)
20th Feb 20259:27 amRNSForm 8.5 (EPT/RI)
20th Feb 20257:00 amRNSPublication of Circular
20th Feb 20257:00 amRNSPublication of Scheme Document
19th Feb 20254:47 pmGNWForm 8.3 - Crimson Tide plc - Octopus Investments
19th Feb 20254:30 pmRNSForm 8 (OPD) - Crimson Tide plc
19th Feb 20253:11 pmRNSForm 8.3 - Crimson Tide Plc
19th Feb 20252:22 pmRNSForm 8.3 - Crimson Tide PLC
19th Feb 202510:47 amRNSForm 8.5 (EPT/RI)
18th Feb 20254:01 pmRNSForm 8.3 - Crimson Tide Plc
17th Feb 20253:39 pmRNSForm 8.3 - Crimson Tide PLC
17th Feb 202510:04 amRNSForm 8.3 - Crimson Tide Plc
14th Feb 202510:38 amRNSForm 8.5 (EPT/NON-RI)
13th Feb 20251:22 pmRNSForm 8.3 - Crimson Tide Plc
13th Feb 202511:47 amRNSForm 8.5 (EPT/RI)
12th Feb 20252:36 pmGNWForm 8.3 - Crimson Tide Plc
12th Feb 20251:12 pmGNWForm 8.3 - [CRIMSON TIDE PLC - Opening Disclosure - 11 02 2025] - (CGAML)
12th Feb 202511:23 amRNSForm 8.3 - Crimson Tide plc
12th Feb 202510:45 amRNSForm 8.5 (EPT/RI)
12th Feb 20258:59 amRNSForm 8.5 (EPT/NON-RI)
11th Feb 20257:00 amRNSRecommended All-Share Merger with Crimson Tide
14th Nov 20243:32 pmRNSHolding(s) in Company
14th Nov 20243:25 pmRNSPDMR Dealing
26th Sep 20247:00 amRNSInterim Results
19th Aug 20247:00 amRNSCrimson Tide Launches Interactive Investor Hub
30th Jul 20247:00 amRNSBoard Changes
11th Jul 20241:07 pmRNSStatement of no intention to make an offer
9th Jul 20248:20 amRNSForm 8.5 (EPT/NON-RI)
27th Jun 20242:45 pmRNSResult of AGM
25th Jun 202412:32 pmRNSForm 8.3 - Crimson Tide PLC

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.